Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
103 (48%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TOPILENE | 0.05% | LOTION | Resolved | 2024-12-13 | 2025-02-06 | 245595 |
| TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2020-04-10 | 2020-04-23 | 111851 |
| TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2024-02-29 | 2024-07-18 | 220989 |
| TEVA-TOPILENE | 0.05% | OINTMENT | Resolved | 2020-06-25 | 2020-10-01 | 118948 |
| TEVA-TOPILENE | 0.05% | OINTMENT | Actual shortage | 2024-08-30 | 2025-05-08 | 236356 |
| TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2020-06-25 | 2020-09-25 | 118942 |
| TEVA-TOPILENE | 0.05% | LOTION | Resolved | 2021-03-11 | 2023-04-28 | 135552 |
| TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2024-02-08 | 2024-07-18 | 218949 |
| TEVA-TOPIRAMATE | 25MG | TABLET | Resolved | 2024-04-11 | 2024-05-23 | 224889 |
| TEVA-TOPIRAMATE | 200MG | TABLET | Resolved | 2023-10-05 | 2024-01-25 | 206398 |
| TEVA-TOPIRAMATE | 100MG | TABLET | Resolved | 2023-07-20 | 2023-10-04 | 199345 |
| TEVA-TOPIRAMATE | 100MG | TABLET | Resolved | 2021-01-28 | 2021-02-11 | 132649 |
| TEVA-TOPIRAMATE | 100MG | TABLET | Actual shortage | 2025-03-13 | 2025-04-10 | 252584 |
| TEVA-TOPIRAMATE | 200MG | TABLET | Resolved | 2020-10-01 | 2020-10-08 | 125482 |
| TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-01-20 | 2022-03-24 | 153147 |
| TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2024-04-18 | 2024-06-29 | 225480 |
| TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2024-12-19 | 2025-03-13 | 246098 |
| TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2023-11-03 | 2023-12-14 | 209119 |
| TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-12-01 | 2022-12-15 | 176800 |
| TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2024-07-04 | 2024-11-14 | 232198 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
| TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81371 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Discontinued | 2025-03-20 | 2025-03-20 | 253186 |
| TEVA-FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256137 |
| TEVA-FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256091 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |